Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Smit

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohortJ W T van der Wel, M Jebbink, D van den Broek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2019
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III studyW J A Witlox, B L T Ramaekers, M A Joore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkersS Trebeschi, S G Drago, N J Birkbak, et al.
British Journal of Cancer|February 27, 2015
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approachA J Hubers, D A M Heideman, S A Burgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2022
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancerJ M van Berge Henegouwen, M Jebbink, L R Hoes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancerP D Bonomi, D Gandara, F R Hirsch, et al.
Nature Communications|November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancerA N Niemeijer, D Leung, M C Huisman, et al.
The European Respiratory Journal|December 2, 2009
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaborationJ K Field, T Liloglou, A Niaz, et al.
ESMO Open|July 14, 2023
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumorsS F Oosting, A A M van der Veldt, R S N Fehrmann, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohortJ W T van der Wel, M Jebbink, D van den Broek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2019
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III studyW J A Witlox, B L T Ramaekers, M A Joore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkersS Trebeschi, S G Drago, N J Birkbak, et al.
British Journal of Cancer|February 27, 2015
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approachA J Hubers, D A M Heideman, S A Burgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2022
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancerJ M van Berge Henegouwen, M Jebbink, L R Hoes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancerP D Bonomi, D Gandara, F R Hirsch, et al.
Nature Communications|November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancerA N Niemeijer, D Leung, M C Huisman, et al.
The European Respiratory Journal|December 2, 2009
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaborationJ K Field, T Liloglou, A Niaz, et al.
ESMO Open|July 14, 2023
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumorsS F Oosting, A A M van der Veldt, R S N Fehrmann, et al.
Pageof 19